Vistin Pharma ASA: Invitation to Q1 2026 conference call

Oslo, Norway, 17 April 2026

Vistin Pharma ASA (VISTN) will release its first quarter results on Friday 24th of April 2026. Vistin Pharma will host a conference call for all shareholders and interested parties on the same day at 08:30 CET. There will be a Q&A session following the management discussion.

The first quarter conference call will be available via web and audio through the following access points:

Webcast: https://edge.media-server.com/mmc/p/req62z7o

Telephone conference (online registration):

https://register-conf.media-server.com/register/BIca3298faa94f4bbb900f07289bc40eb7 

*****

For further information, please contact:

Alexander Karlsen
CFO
+47 97053621
[email protected]

About Vistin Pharma | www.vistin.com

Vistin Pharma is a Norwegian pharmaceutical company producing Metformin Hydrochloride (API). The Metformin is also available as Direct Compressible lubricated granules. As a solely dedicated European Metformin producer, Vistin Pharma is a well-positioned supplier to leading pharmaceutical companies. Vistin Pharma is headquartered in Oslo, Norway, and has highly qualified employees and a dedicated manufacturing facility in Kragerø.

You May Also Be Interested In

• NGen: Canada's Manufacturers Must Out-Compete, Not Just Out-Wait, American Protectionism
• Kering: Monthly statement on the total number of shares and voting rights (August 2026)
• Little League® and Boys & Girls Clubs of America Announce Partnership to Expand Opportunities for Children and Communities